Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: August 18, 2008
Last updated: April 16, 2014
Last verified: March 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):